Nath Bio-Genes
Nath Bio-Genes Share Price Chart
Nath Bio-Genes last traded at ₹135.52 (2026-10-13). Over the past month the stock moved -9.4%, three months the stock moved -20.7%, year the stock moved -18.1%. Its closing range over 52 weeks is ₹129.65 – ₹196.00, with the latest close 30.9% below the high.
Closing prices up to 2026-10-13.
About Nath Bio-Genes
Incorporated in 1993, Nath Bio-Genes Ltd is in the business of Production, Processing, and Marketing of Hybrid and GM Seeds[1]
Business Overview:[1][2][3] NBGL is a flagship company of Nath Group. It is an agri-tech company in the business of developing and supplying quality BT, hybrid, and varietal seeds to farmers at affordable prices. It does the production and processing of commercial and vegetable seeds on lands taken on lease from various growers /farmers throughout India. The company enters into seed production agreements with these farmers/growers and compensates them for various cultivation expenses based on the rate agreement entered into
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Nath Bio-Genes reported sales of ₹328.00 crore (+15.5%) and net profit of ₹32.00 crore (+14.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 328.00 | 35.00 | 11.00 | 32.00 | 16.98 |
| Mar 2026 | 52.00 | 4.00 | 9.00 | 0.00 | -0.01 |
| Dec 2025 | 66.00 | 4.00 | 5.00 | 2.00 | 0.84 |
| Sep 2025 | 44.00 | 6.00 | 14.00 | 5.00 | 2.54 |
| Jun 2025 | 284.00 | 29.00 | 10.00 | 28.00 | 14.88 |
| Mar 2025 | 52.00 | 0.00 | 0.80 | 1.00 | 0.78 |
| Dec 2024 | 37.00 | 8.00 | 22.00 | 3.00 | 1.39 |
| Sep 2024 | 32.00 | 5.00 | 15.00 | 1.00 | 0.58 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +39.1% | +15.6% | +20.9% | +16.4% | +37.5% | +78.4% | +0.0% | +15.5% |
| Operating profit growth | +0.0% | +33.3% | -100.0% | -21.6% | +20.0% | -50.0% | – | +20.7% |
| Net profit growth | -50.0% | -25.0% | -66.7% | -15.2% | +400.0% | -33.3% | -100.0% | +14.3% |
| EPS growth | -26.6% | -31.2% | -43.5% | -15.2% | +337.9% | -39.6% | -101.3% | +14.1% |
| OPM % | 15.0% | 22.0% | 0.8% | 10.0% | 14.0% | 5.0% | 9.0% | 11.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Nath Bio-Genes reported sales of ₹445.00 crore (+21.9%) and net profit of ₹42.00 crore (+7.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 445.00 | 52.00 | 12.00 | 42.00 | 21.91 |
| Mar 2025 | 365.00 | 50.00 | 14.00 | 39.00 | 20.31 |
| Mar 2024 | 248.00 | 50.00 | 20.00 | 40.00 | 20.85 |
| Mar 2023 | 234.00 | 49.00 | 21.00 | 35.00 | 18.43 |
| Mar 2022 | 230.00 | 37.00 | 16.00 | -67.00 | -35.46 |
| Mar 2013 | 109.00 | 20.00 | 18.00 | 12.00 | 7.34 |
| Mar 2012 | 97.00 | 15.00 | 15.00 | 9.00 | 5.75 |
| Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | +12.4% | +111.0% | +1.7% | +6.0% | +47.2% | +21.9% |
| Operating profit growth | +33.3% | +85.0% | +32.4% | +2.0% | +0.0% | +4.0% |
| Net profit growth | +33.3% | -658.3% | – | +14.3% | -2.5% | +7.7% |
| EPS growth | +27.7% | -583.1% | – | +13.1% | -2.6% | +7.9% |
| OPM % | 18.0% | 16.0% | 21.0% | 20.0% | 14.0% | 12.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Nath Bio-Genes.
Get Free AI Stock Analysis FREE →Latest News
-
Golden Cross Confirmed: Do Nath Bio-Genes' Other Technical Indicators Agree?
-
Nath Bio-Genes Reports Audited FY26 Results; Recommends Rs. 2/- Dividend Per Share - scanx.trade
-
Nath Bio-Genes Reports Audited FY26 Results; Recommends Rs. 2/- Dividend Per Share - scanx.trade
-
Nath Bio-Genes (India) reports consolidated net loss of Rs 0.01 crore in the March 2026 quarter - Business Standard
-
Nath Bio-Genes reports Profit after tax of Rs 37.87 Mln, in the March 2026 quarter
-
Nath Bio-Genes Releases Q4 & FY26 Investor Presentation: Revenue Grows to INR 4,316 Mn, Net Worth Reaches INR 6,893 Mn - scanx.trade
-
Nath Bio-Genes reports Profit after tax of Rs 37.87 Mln, in the March 2026 quarter
Frequently Asked Questions
What is the share price of Nath Bio-Genes today?
Nath Bio-Genes shares were last quoted at ₹135.52 (-1.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Nath Bio-Genes?
Nath Bio-Genes has a price-to-earnings (P/E) ratio of 7.78 and a price-to-book (P/B) ratio of 0.40. The industry P/E is 10.48.
What is the 52-week high and low of Nath Bio-Genes?
The 52-week high of Nath Bio-Genes is ₹207.00 and the 52-week low is ₹126.75.
What is the market cap of Nath Bio-Genes?
The market capitalisation of Nath Bio-Genes is about ₹284.77 crore.
How did Nath Bio-Genes perform in its latest quarterly results?
In the latest quarter (Jun 2026), Nath Bio-Genes reported sales of ₹328.00 crore (+15.5%) and net profit of ₹32.00 crore (+14.3%), compared with the same quarter last year.
Is Nath Bio-Genes a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Nath Bio-Genes has a 3-year ROE of 6.00%, 3-year profit growth of 1.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Nath Bio-Genes?
Promoters hold about 45.60% of Nath Bio-Genes.
Which sector does Nath Bio-Genes belong to?
Nath Bio-Genes belongs to the Agriculture sector.